Abbott Laboratories Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Abbott Laboratories income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue44.3341.9540.1143.6543.0834.6131.9030.58
Cost of Revenue19.1920.6317.9819.0818.5415.0013.2312.71
Gross Profit25.1421.3322.1324.5724.5419.6118.6717.87
Operating Expenses
Research & Development2.892.822.742.742.742.422.442.30
Selling, General & Administrative12.1811.6510.9510.7011.329.709.779.74
Operating Expenses16.7514.4715.6615.4616.1112.1212.2114.22
Operating Income8.396.836.489.118.435.364.533.65
Other Income/Expense
Interest Income0.000.340.390.180.040.050.000.11
Interest Expense-0.190.60-0.64-0.560.53-0.550.000.83
Other Income/Expense0.580.19-0.48-0.09-0.28-0.10-0.13-0.06
Income
Income Before Tax8.477.016.668.318.214.974.082.87
Income Tax Expense1.94-6.390.941.371.140.500.390.54
Net Income6.5213.405.726.937.074.503.692.37
Net Income - Continuous Operations0.0013.405.726.937.070.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.000.00
EBITDA11.4910.839.9112.3812.288.847.766.98
EBIT8.397.016.669.118.745.514.753.70
Depreciation & Amortization3.103.221.973.272.051.201.082.18
Earnings Per Share
Basic EPS4.008.003.004.004.003.002.001.00
Diluted EPS4.008.003.004.004.003.002.001.00
Basic Shares Outstanding1.751.731.741.751.781.771.771.76
Diluted Shares Outstanding1.751.751.741.761.781.771.771.77